Journal Club
1. Spectrum Of Pulmonary Fungal Pathogens And Antifungal Drug Susceptibility Among TB Relapse And Retreatment Samples At Selected Health Facilities In Kenya - PhD Research Update
0
IAVI-W001 Study Launched at the KAVI-Institute of Clinical Research
On 24th September 2019, the first volunteer was enrolled in the IAVI-W001 study at the KAVI-Institute of Clinical Research (KAVI-ICR) of the University of Nairobi. The occasion marks the beginning of the 12th HIV vaccine clinical trial to be conducted at KAVI-ICR since 2001. This is a first-in-human study that uses a Native-trimer HIV envelope design that will hopefully stimulate broadly neutralizing antibodies against HIV.
0
KAVI-ICR Hosts the National Academy of Medicine to Discuss Advancing Women’s Health Research Leadership in Africa
KAVI-Institute of Clinical Research at the University of Nairobi (UoN) proudly hosted a high-level delegation from the U.S. National Academy of Medicine (NAM) as part of the Academy’s Listening Sessions initiative. This effort aims to understand and address the barriers faced by mid-career researchers particularly in the realm of women’s health in becoming Principal Investigators (PIs).